Merck (NYSE:MRK) announced that a group of independent advisors to the U.S. CDC unanimously voted to recommend its newly approved pneumonia vaccine, Capvaxive, for adults aged 65 years and older.

This past fall, the Centers for Disease Control and Prevention changed the recommended age for getting the vaccine for pneumococcal pneumonia from those 65 and ... spreads by coughing or close contact ...

There are at least 100 strains of pneumococcus, the cause of pneumonia. Over the years, the vaccines have been improved to ...

For the first time this year, the US Centers for Disease Control and Prevention says that adults as young as 50 can get vaccinated against a pneumococcal pneumonia, significantly lowering the ...

Advisory Committee on Immunization Practices (ACIP) has lowered the recommended age for pneumococcal vaccination from 65 to ...

There are two types of pneumonia vaccines available to prevent specific strains of this bacteria. The Centers for Disease Control and Prevention (CDC ... strict sourcing guidelines and relies ...

But are you protected against pneumonia, a common complication of each of the above illnesses? If you haven’t received the pneumonia (pneumococcal) vaccine, you’re among the majority of Americans.

This past fall, the Centers for Disease Control and Prevention changed the recommended age for getting the vaccine for pneumococcal pneumonia from ... close contact. The CDC justified the revised ...